197 related articles for article (PubMed ID: 38084790)
1. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
2. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
3. Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model.
Spurgeon ME; Townsend EC; Blaine-Sauer S; McGregor SM; Horswill M; den Boon JA; Ahlquist P; Kalan L; Lambert PF
mBio; 2024 Jun; 15(6):e0093324. PubMed ID: 38742830
[TBL] [Abstract][Full Text] [Related]
4. Expanded Basal Compartment and Disrupted Barrier in Vocal Fold Epithelium Infected with Mouse Papillomavirus MmuPV1.
King RE; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632798
[TBL] [Abstract][Full Text] [Related]
5. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
6. A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.
Blaine-Sauer S; Shin MK; Matkowskyj KA; Ward-Shaw E; Lambert PF
mBio; 2021 Aug; 12(4):e0161121. PubMed ID: 34281391
[TBL] [Abstract][Full Text] [Related]
7. Sexual transmission of murine papillomavirus (MmuPV1) in
Spurgeon ME; Lambert PF
Elife; 2019 Oct; 8():. PubMed ID: 31621578
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Models of Laryngeal Papillomavirus Infection: A Scoping Review.
King RE; Bilger A; Rademacher J; Lambert PF; Thibeault SL
Laryngoscope; 2023 Dec; 133(12):3256-3268. PubMed ID: 37227124
[TBL] [Abstract][Full Text] [Related]
9. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
10. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.
Xue XY; Majerciak V; Uberoi A; Kim BH; Gotte D; Chen X; Cam M; Lambert PF; Zheng ZM
PLoS Pathog; 2017 Nov; 13(11):e1006715. PubMed ID: 29176795
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
12. Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.
Cladel NM; Budgeon LR; Cooper TK; Balogh KK; Christensen ND; Myers R; Majerciak V; Gotte D; Zheng ZM; Hu J
J Gen Virol; 2017 Oct; 98(10):2520-2529. PubMed ID: 28942760
[TBL] [Abstract][Full Text] [Related]
13. An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.
Wei T; Buehler D; Ward-Shaw E; Lambert PF
mBio; 2020 May; 11(3):. PubMed ID: 32398315
[TBL] [Abstract][Full Text] [Related]
14. Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Brendle SA; Christensen ND; Schell TD; Hu J
Sci Rep; 2017 Dec; 7(1):16932. PubMed ID: 29208932
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
bioRxiv; 2023 Apr; ():. PubMed ID: 36993217
[TBL] [Abstract][Full Text] [Related]
16. Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
Wang W; Spurgeon ME; Pope A; McGregor S; Ward-Shaw E; Gronski E; Lambert PF
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2214225120. PubMed ID: 36917668
[TBL] [Abstract][Full Text] [Related]
17. The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
Antiviral Res; 2023 Aug; 216():105667. PubMed ID: 37429527
[TBL] [Abstract][Full Text] [Related]
18. The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections.
Christensen ND; Chen KM; Hu J; Stairs DB; Sun YW; Aliaga C; Balogh KK; Atkins H; Shearer D; Li J; Brendle SA; Gowda K; Amin S; Walter V; Viscidi R; El-Bayoumy K
Chem Biol Interact; 2021 Jan; 333():109321. PubMed ID: 33186600
[TBL] [Abstract][Full Text] [Related]
19. Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model.
Brendle SA; Li JJ; Walter V; Schell TD; Kozak M; Balogh KK; Lu S; Christensen ND; Zhu Y; El-Bayoumy K; Hu J
Pathogens; 2023 Dec; 12(12):. PubMed ID: 38133335
[TBL] [Abstract][Full Text] [Related]
20. Role of E6 in Maintaining the Basal Cell Reservoir during Productive Papillomavirus Infection.
Saunders-Wood T; Egawa N; Zheng K; Giaretta A; Griffin HM; Doorbar J
J Virol; 2022 Mar; 96(5):e0118121. PubMed ID: 35019722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]